INDEX / DIRECTORY / PROCTER & GAMBLE / MILITARY

Procter & Gamble MILITARY

MILITARY AUDIT UPDATED 2026-09-11
Military Score 0.00 /10 D Procter & Gamble - BDS-1000 347
Military 0.00

Evidence-only forensic audit. Scoring happens downstream - see the main dossier for the composite assessment.

Forensic audits like this are reader-funded - no sponsors, no ads. Support OpenIntel →

Direct Defence Contracting & Procurement

The Procter & Gamble Company’s FY2025 filing defines P&G as the registrant and its subsidiaries and describes its business as creating, manufacturing, marketing, and distributing daily-use consumer products through retail, e-commerce, direct-to-consumer, distributor, wholesale, pharmacy, and professional channels 1.

No public evidence identified.

The bounded research record did not identify an Israeli Ministry of Defense, IDF, Israel Prison Service, Border Police, Israeli-security, or Israeli defence-prime contract, tender award, framework agreement, SIBAT listing, or defence-exhibition listing involving P&G or P&G Israel M.D.O. Ltd. 1, 2, 3.

A 2005 Israeli competition-authority record concerns P&G’s acquisition of Gillette and characterises the parties’ principal business as toiletry products rather than defence goods or services 3.

The same record identifies S. Schestowitz Ltd. as an independent Israeli distributor of Gillette that Gillette did not control, supporting a historical civilian distribution relationship but not military or security end-use 3.

Dual-Use Products & Tactical Variants

The reviewed corporate disclosures, Israeli merger material, and targeted procurement-search results did not identify a P&G tactical, ruggedised, military-specified, or Israeli-security-force-specific product line 1, 2, 3.

The reviewed evidence did not identify an Israeli military end-user certificate or export-licence decision for P&G products 1, 2, 3.

P&G’s disclosed commercial scope is daily-use consumer products, and the record does not document a tactical variant or military calibration of those products 1.

Heavy Machinery, Construction & Infrastructure

The evidence reviewed did not identify P&G machinery or equipment used in settlement construction, demolitions, barrier work, checkpoints, military installations, or other construction or engineering activity in occupied territory 3, 4.

The Israeli merger record describes P&G as a toiletries business, while the identified historical supply-chain material concerns nonwoven hygiene fabrics rather than heavy machinery or construction equipment 3, 4, 5.

P&G’s FY2025 subsidiary exhibit lists P&G Israel M.D.O. Ltd. in Israel but does not establish operations in the West Bank, East Jerusalem, or the Golan Heights 2.

Supply Chain Integration with Defence Primes

The reviewed evidence did not identify P&G supplies of components, systems, materials, manufacturing services, joint development, or licensed production for Elbit, Israel Aerospace Industries, Rafael, IMI/Elbit Land, or another identified Israeli defence prime 1, 2, 6, 7.

Indorama Ventures reported that P&G had graded Indorama and its Israeli subsidiary Avgol as “best-in-class” suppliers under P&G’s Sustainable Supply Chain Innovation Program 5.

Avgol describes its business as producing high-performance nonwoven fabrics for baby-diaper, adult-incontinence, and feminine-hygiene markets 4.

This documented supplier relationship concerns civilian hygiene materials and does not establish defence-prime integration, military end-use, or current continuation of the relationship 4, 5.

A civil-society lead concerning historical P&G sourcing from Avgol’s Barkan facility remains unresolved because the underlying Israeli securities filing cited for sales figures and facility-specific attribution was not independently retrieved in this domain’s research record 8.

Logistical Sustainment & Base Services

The reviewed materials did not identify P&G provision of catering, transport, fuel, waste services, facilities management, telecommunications, freight forwarding, port handling, or comparable logistical sustainment to Israeli military or security installations 1, 6, 7.

The record likewise did not identify P&G logistical services for Israeli arms shipments or military freight 6, 7.

Munitions, Weapons Systems & Strategic Platforms

The reviewed evidence did not identify P&G manufacture or supply of lethal platforms, ammunition, explosive or propellant materials, missile-defence components, strategic-platform components, or weapons-calibrated subsystems for Israeli forces 1, 6, 7.

P&G’s disclosed business model centres on daily-use consumer products, and the reviewed filings do not disclose a weapons, munitions, or military-platform product line 1.

Export Licensing, Regulatory & Legal History

The bounded record did not identify export-licence grants, denials, suspensions, sanctions investigations, embargo enforcement, or litigation concerning a P&G defence supply relationship with Israel 1, 2, 3, 6, 7.

The 2005 Israeli government record addresses competition approval for P&G’s Gillette transaction rather than an export-control or defence-procurement matter 3.

A 2017 shareholder proposal stated that P&G had operations in Palestine/Israel, but the filing records the proposal proponent’s assertions and does not document military supply or settlement operations 9.

Civil Society Scrutiny & Documented Investigations

The supplied document-scoped review found no mention of Procter & Gamble in the UN Special Rapporteur’s 2025 report A/HRC/59/23 or the OHCHR’s 2023 settlement-business database, which is not evidence of broader relationship-wide absence 6, 7.

The 2025 proxy identifies B. Marc Allen as a director nominee and records his prior senior roles at Boeing, including President of Boeing International and Chief Strategy Officer 10.

P&G’s proxy describes Boeing as operating in aerospace, commercial jetliners, and military defence systems, while Boeing’s 2022 annual report identifies Allen as its Chief Strategy Officer and an Executive Council member 10, 11.

These disclosures establish Allen’s prior defence-industry career connection but do not establish an Israel-, IDF-, IMOD-, settlement-, or Palestine-related activity by Allen, Boeing, P&G, or P&G Israel M.D.O. Ltd. 10, 11.

P&G’s 2025 proxy lists The Vanguard Group at 9.60% and BlackRock, Inc. at 6.65% as beneficial owners above 5%, based on 2023 Schedule 13G/A information, and neither disclosed holding reaches a 10% threshold 10.

The record identifies Shailesh Jejurikar as elected President and CEO effective 1 January 2026 and Jon R. Moeller as becoming Executive Chairman on that date 12.

Footnotes

  1. https://www.sec.gov/Archives/edgar/data/80424/000008042425000076/pg-20250630.htm ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  2. https://www.sec.gov/Archives/edgar/data/80424/000008042425000076/fy242510-kexhibit21.htm ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  3. https://www.gov.il/BlobFolder/legalinfo/6029/he/mergers_file_23062005b.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9

  4. https://www.avgol.com/avgol-invests-in-indian-business-with-relocation-of-smms-line-plus-additional-melt-blown-line-in-same-location/ ↩ ↩2 ↩3 ↩4

  5. https://www.indoramaventures.com/storage/downloads/beacon/en/2019-vol23.pdf ↩ ↩2 ↩3

  6. https://docs.un.org/en/A/HRC/59/23 ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  7. https://docs.un.org/en/A/HRC/53/25 ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  8. https://investigate.afsc.org/company/indorama-ventures ↩

  9. https://d18rn0p25nwr6d.cloudfront.net/CIK-0000080424/d480d947-beb1-4bba-a959-8712f011052b.pdf ↩

  10. https://www.sec.gov/Archives/edgar/data/80424/000119312525191749/d875382ddef14a.htm ↩ ↩2 ↩3 ↩4

  11. https://www.sec.gov/Archives/edgar/data/12927/000119312523059904/d424500dars.pdf ↩ ↩2

  12. https://www.sec.gov/Archives/edgar/data/80424/000008042425000061/ceotransition.htm ↩